Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017.

Chiong, Edmund; Murphy, Declan; Akaza, Hideyuki; Buchan, Nicholas; Chung, Byung; Kanesvaran, Ravindran; Khochikar, Makarand; Letran, Jason; Lojanapiwat, Bannakij; Ng, Chi-fai; Ong, Teng; Pu, Yeong-Shiau; Saad, Marniza; Schubach, Kathryn; Turkeri, LEVENT; Umbas, Rainy; Vu Le Chuyen, Vu; Williams, Scott; Ye, Ding-Wei; Davis, Ian

doi:10.1111/bju.14489

Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017.

Atıf İçin Kopyala

Chiong E., Murphy D. G., Akaza H., Buchan N. C., Chung B. H., Kanesvaran R., ...Daha Fazla

BJU international, cilt.123, sa.1, ss.22-34, 2019 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 123 Sayı: 1
Basım Tarihi: 2019
Doi Numarası: 10.1111/bju.14489
Dergi Adı: BJU international
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.22-34
Anahtar Kelimeler: advanced prostate cancer, castration-naive prostate cancer, castration-resistant prostate cancer, high-risk localised prostate cancer, oligometastatic prostate cancer, cost and access to treatment, ACETATE PLUS PREDNISONE, POST-HOC ANALYSIS, ABIRATERONE ACETATE, CHEMOTHERAPY-NAIVE, DOUBLE-BLIND, RADICAL PROSTATECTOMY, SURVIVAL ANALYSIS, PREVAIL TRIAL, PHASE-II, CASTRATION
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

ObjectiveThe Asia Pacific Advanced Prostate Cancer Consensus Conference (APAC APCCC 2018) brought together 20 experts from 15 APAC countries to discuss the real-world application of consensus statements from the second APCCC held in St Gallen in 2017 (APCCC 2017).